Leveraging Bioorthogonal Click Chemistry to Improve 225Ac-Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-1650
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Pretargeted Imaging and Radioimmunotherapy of Cancer Using Antibodies and Bioorthogonal Chemistry

Frontiers in Medicine
Medicine
2014English

Pancreatic Ductal Adenocarcinoma With Cystic Features

HPB
HepatologyGastroenterology
2016English

Features of Immunophenotype of Pancreatic Ductal Adenocarcinoma

Zaporozhye Medical Journal
2014English

Non-Coding RNAs in Pancreatic Ductal Adenocarcinoma

Frontiers in Oncology
Cancer ResearchOncology
2020English

Overexpression of Mesothelin in Pancreatic Ductal Adenocarcinoma (PDAC)

International Journal of Medical Sciences
Medicine
2020English

Clinical Significance of MUC13 in Pancreatic Ductal Adenocarcinoma

HPB
HepatologyGastroenterology
2018English

Tumor-Stroma Interactions in Pancreatic Ductal Adenocarcinoma

Molecular Cancer Therapeutics
Cancer ResearchOncology
2007English

Pancreatic Ductal Adenocarcinoma inBRCA2mutation Carriers: Table 1

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2016English

Image-Based Molecular Phenotyping of Pancreatic Ductal Adenocarcinoma

Journal of Clinical Medicine
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy